Melanoma and Skin Cancer Trials and the Victorian Heart Institute are leading an Australian-first trial to determine if a common cholesterol medication can reduce the risk of heart attacks in melanoma patients treated with cancer therapy.

A $110,000 donation to a new trial treating melanoma brain metastases will help open additional research sites around Australia, offering hope to patients, like Peter Wilson, who have melanoma that has spread to the brain.

MASC Trials, MSCAN and BlazeAid have partnered to deliver sun safety educational videos for BlazeAid volunteers so they know how to protect their skin during frontline disaster response work.